Literature DB >> 2643457

Association of early malignant melanoma with nevocytic nevi.

W Stolz1, C Schmoeckel, M Landthaler, O Braun-Falco.   

Abstract

The percentage of histologically associated malignant nevocytic nevi is essential for establishing concepts of histogenesis. The literature abounds with studies of this association. However, the results are conflicting and vary between 4% and 72% of malignant melanomas with associated nevocytic nevi with a maximum frequency between 20% and 30%. These different values could be partially explained by the fact that tumors in more advanced stages might have "overgrown" preexisting nevocytic cells. For this reason, only cases of early stage malignant melanoma (tumor thickness less than or equal to 1.5 mm; level of invasion less than or equal to III) were included in this study (n = 150). Thirty-three (22%) of 150 cases of malignant melanoma were associated with nevocytic nevi. In an additional 6.1% of the cases there was a possible but doubtful association. In 45.4% of the cases the nevus cells could be detected below the tumor, in 18.2% they could be seen at the laterally adjacent sides, and in 36.4% they were found at both sites. Fifty percent showed junctional activity from the nevocytic nevi located to the side of the melanoma. We conclude that the finding of approximately 27% of nevocytic nevi with junctional activity among the nevocytic nevi associated with malignant melanoma could be an indicator that at least some malignant melanomas develop within or next to a preexisting and still proliferating nevocytic nevus.

Entities:  

Mesh:

Year:  1989        PMID: 2643457     DOI: 10.1002/1097-0142(19890201)63:3<550::aid-cncr2820630325>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm.

Authors:  Vanessa Priscilla Martins da Silva; Juliana Kida Ikino; Mariana Mazzochi Sens; Daniel Holthausen Nunes; Gabriella Di Giunta
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Mutational status of naevus-associated melanomas.

Authors:  D Shitara; G Tell-Martí; C Badenas; M M S S Enokihara; L Alós; A B Larque; N Michalany; J A Puig-Butille; C Carrera; J Malvehy; S Puig; E Bagatin
Journal:  Br J Dermatol       Date:  2015-06-19       Impact factor: 9.302

3.  De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.

Authors:  Rachel M Cymerman; Yongzhao Shao; Kun Wang; Yilong Zhang; Era C Murzaku; Lauren A Penn; Iman Osman; David Polsky
Journal:  J Natl Cancer Inst       Date:  2016-05-27       Impact factor: 13.506

4.  Skin cancer of the head and neck.

Authors:  Yun-Hsuan Ouyang
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

5.  Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

Authors:  Liesbeth C W Vredeveld; Patricia A Possik; Marjon A Smit; Katrin Meissl; Chrysiis Michaloglou; Hugo M Horlings; Abderrahim Ajouaou; Pim C Kortman; David Dankort; Martin McMahon; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

6.  Wnt signaling potentiates nevogenesis.

Authors:  Jeff S Pawlikowski; Tony McBryan; John van Tuyn; Mark E Drotar; Rachael N Hewitt; Andrea B Maier; Ayala King; Karen Blyth; Hong Wu; Peter D Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 7.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

8.  Clinicopathological, Genetic and Survival Advantages of Naevus-associated Melanomas: A Cohort Study.

Authors:  Xavier Bosch-Amate; Sebastian Podlipnik; Constanza Riquelme-Mc Loughlin; Cristina Carrera; Alicia Barreiro-Capurro; Adriana García-Herrera; Llucia Alós; Josep Malvehy; Susana Puig
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

9.  NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.

Authors:  Philipp Tschandl; Anna Sophie Berghoff; Matthias Preusser; Sebastian Burgstaller-Muehlbacher; Hubert Pehamberger; Ichiro Okamoto; Harald Kittler
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

10.  Mitotic Stress Is an Integral Part of the Oncogene-Induced Senescence Program that Promotes Multinucleation and Cell Cycle Arrest.

Authors:  Dina Dikovskaya; John J Cole; Susan M Mason; Colin Nixon; Saadia A Karim; Lynn McGarry; William Clark; Rachael N Hewitt; Morgan A Sammons; Jiajun Zhu; Dimitris Athineos; Joshua D G Leach; Francesco Marchesi; John van Tuyn; Stephen W Tait; Claire Brock; Jennifer P Morton; Hong Wu; Shelley L Berger; Karen Blyth; Peter D Adams
Journal:  Cell Rep       Date:  2015-08-20       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.